Evidence is emerging that the major T- and B-cell response in multiple
sclerosis (MS) is directed to a region of myelin basic protein (MBP)
between residues 84 and 103. In rodent models of MS, immunization to t
his component of MBP evokes experimental autoimmune encephalomyelitis
(EAE). T cells found in EAE lesions show similarities in the VJ and VD
J regions of their alpha and beta chains with T cells in MS lesions, a
nd with T cells that are specific for MBPp84-103 isolated from patient
s with MS. If this region of MBP is critical in the pathogenesis of MS
, then therapy aimed at controlling the immune response to this immuno
dominant region of MBP may be beneficial in treating MS.